Novant Health Matthews Medical Center

Matthews, North Carolina 28240

0 studies enrolling now · 3 studies all time

What they study most

BRCA 1 Gene Mutation, BRCA 2 Gene Mutation, Breast Neoplasms, Heart Failure, Stroke, Transient Ischemic Attack

Studies at this site

• TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure — Completed
• A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) — Completed
• Comprehensive Post-Acute Stroke Services — Completed